A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors.
about
Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer.A dose escalating study of oxaliplatin and high dose weekly leucovorin and 5-Fluorouracil in patients with advanced solid tumors.Salvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: a multicenter phase II study.Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patientsA dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumoursGemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.A two-cohort phase I study of weekly oxaliplatin and gemcitabine, then oxaliplatin, gemcitabine, and erlotinib during radiotherapy for unresectable pancreatic carcinoma.Oxaliplatin for the treatment of ovarian cancer.Rituximab, gemcitabine and oxaliplatin: an effective regimen in patients with refractory and relapsing mantle cell lymphoma.
P2860
Q33366782-4F436D83-7A56-4F94-9C8D-5320BBE2FAE9Q33368773-09A7E971-0951-4F22-87EC-CDB44A31598CQ33373017-22AB509C-4BCC-466E-AEAF-D5F7C1CD2F5AQ33415922-7E469711-5127-4ACD-A40F-837ABC36D84AQ34343973-2D47F9E4-61C7-4E9C-B2C1-BCC6D48EA132Q36608636-3E9E478F-0C69-4B80-9553-39BF22D337C1Q37113732-C2FB9790-05CE-4058-BBD4-BEAAAD9C1E5AQ37508315-FF375047-38F2-485E-B243-BD502AF11454Q38540596-47DF6AF4-55B2-4FC5-8120-FA0C367429FAQ46909218-5ED29DC2-5F24-4C1C-ABD6-2F65A812B44D
P2860
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
A dose-escalation and pharmaco ...... ts with advanced solid tumors.
@ast
A dose-escalation and pharmaco ...... ts with advanced solid tumors.
@en
type
label
A dose-escalation and pharmaco ...... ts with advanced solid tumors.
@ast
A dose-escalation and pharmaco ...... ts with advanced solid tumors.
@en
prefLabel
A dose-escalation and pharmaco ...... ts with advanced solid tumors.
@ast
A dose-escalation and pharmaco ...... ts with advanced solid tumors.
@en
P2093
P356
P1433
P1476
A dose-escalation and pharmaco ...... ts with advanced solid tumors.
@en
P2093
C Kouroussis
D Mavroudis
J Souglakos
K Kalbakis
M Marselos
M Nikolaidou
N Androulakis
N Vardakis
P304
P356
10.1093/ANNONC/MDG063
P577
2003-02-01T00:00:00Z